title: Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
abstract: OBJECTIVE
  To determine the changing incidence of and mortality from cutaneous malignant melanoma in Scotland from 1979 to 1994.
  
  
  METHODS
  Detailed registration of clinical and pathological features, surgical and other treatment, and follow up of all cases of cutaneous malignant melanoma diagnosed from 1979 to 1994 and registered with specialist database for Scotland.
  
  
  METHODS
  Scotland.
  
  
  METHODS
  6288 patients with invasive primary cutaneous malignant melanoma diagnosed between 1 January 1979 and 31 December 1994.
  
  
  RESULTS
  The annual age standardised incidence of cutaneous malignant melanoma rose significantly from 3.5 to 7.8 per 100,000 per year in men and from 6.8 to 12.3 per 100,000 per year in women (P < 0.001 for both). World standardised rates increased from 2.7 to 6.0 per 100,000 per year in men and 4.6 to 8.50 per 100,000 in women. The incidence of melanoma continued to increase significantly in men of all ages during the study, but the rate stabilised in women after 1986. Mortality from cutaneous malignant melanoma was 1.3 per million per annum in men in 1979, rising to 2.3 per million per annum in 1994 (P < 0.01); it was 2.4 per million per annum in women in 1979, falling to 1.9 per million per annum in 1994 (P = 0.09). The underlying mortality trends showed a continuing rise for men but a downward trend for women that was not significant (P = 0.09). In men, melanoma free survival was 69% at 5 years and 61% at 10 years; in women the corresponding rates were 82% and 75%. Younger patients had higher survival rates, which were not entirely explained by thinner tumours. Over the 15 year period, survival rates improved by 12% overall, only partly owing to thinner tumours.
  
  
  CONCLUSIONS
  In Scotland the incidence of melanoma in women has stabilised, while mortality associated with melanoma in women shows a downward trend.
authors.affiliation: Department of Dermatology, University of Glasgow.
authors.forename: R M
authors.initials: RM
authors.lastname: MacKie
authors.forename: D
authors.initials: D
authors.lastname: Hole
authors.forename: J A
authors.initials: JA
authors.lastname: Hunter
authors.forename: R
authors.initials: R
authors.lastname: Rankin
authors.forename: A
authors.initials: A
authors.lastname: Evans
authors.forename: K
authors.initials: K
authors.lastname: McLaren
authors.forename: M
authors.initials: M
authors.lastname: Fallowfield
authors.forename: A
authors.initials: A
authors.lastname: Hutcheon
authors.forename: A
authors.initials: A
authors.lastname: Morris
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008545:Melanoma / Q000401:mortality* / Q000473:pathology; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011379:Prognosis; D012606:Scotland / Q000453:epidemiology; D012878:Skin Neoplasms / Q000401:mortality* / Q000473:pathology; D016019:Survival Analysis; D015996:Survival Rate